Ginkgo Bioworks Holdings, Inc.

On March 6, 2025, the Compensation Committee approved a performance-based equity incentive program (the “Performance Equity Program”), under which performance-vesting restricted stock units (“PSUs”) were granted to substantially all employees, including Mr. Dmytruk but not including Dr. Kelly and Dr. Shetty. The program provides for PSU awards under the 2021 Plan, which will be eligible to vest based on both continued employment and the achievement of performance metrics for the employee’s business unit or function over a one-year performance period from January 1, 2025 through December 31, 2025. PSU awards may vest between 0% and 100% of target. No PSU awards are expected to vest until the Compensation Committee certifies 2025 performance in early 2026.